Tacere Therapeutics Overview

  • Year Founded
  • 2006

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $1.5M

Tacere Therapeutics General Information

Description

Developer of novel therapeutics intended to treat hepatitis C.

Contact Information

Website
www.tacerebio.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 4900 Hopyard Road
  • Suite 100
  • Pleasanton, CA 94588
  • United States
+1 (855)
Primary Industry
Drug Discovery
Acquirer
Benitec Biopharma
Vertical(s)
Life Sciences
Corporate Office
  • 4900 Hopyard Road
  • Suite 100
  • Pleasanton, CA 94588
  • United States
+1 (855)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Tacere Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 30-Oct-2012 $1.5M Completed Generating Revenue
1. Seed Round 01-Dec-2006 Completed Generating Revenue
To view Tacere Therapeutics’s complete valuation and funding history, request access »

Tacere Therapeutics Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Hokkaido Venture Capital Venture Capital Minority
To view Tacere Therapeutics’s complete investors history, request access »

Ready to get started?

Request a free trial

Tacere Therapeutics FAQs

  • When was Tacere Therapeutics founded?

    Tacere Therapeutics was founded in 2006.

  • Where is Tacere Therapeutics headquartered?

    Tacere Therapeutics is headquartered in Pleasanton, CA.

  • What industry is Tacere Therapeutics in?

    Tacere Therapeutics’s primary industry is Drug Discovery.

  • Is Tacere Therapeutics a private or public company?

    Tacere Therapeutics is a Private company.

  • What is the current valuation of Tacere Therapeutics?

    The current valuation of Tacere Therapeutics is .

  • What is Tacere Therapeutics’s current revenue?

    The current revenue for Tacere Therapeutics is .

  • How much funding has Tacere Therapeutics raised over time?

    Tacere Therapeutics has raised $8K.

  • Who are Tacere Therapeutics’s investors?

    Hokkaido Venture Capital has invested in Tacere Therapeutics.

  • When was Tacere Therapeutics acquired?

    Tacere Therapeutics was acquired on 30-Oct-2012.

  • Who acquired Tacere Therapeutics?

    Tacere Therapeutics was acquired by Benitec Biopharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process